Figure S9.
TLS score for immunotherapeutic response prediction in non-GC cohorts. Survival analysis and proportion comparisons of therapeutic results between high- and low-TLS score in GSE78220 (A) and GSE176307 (B). TLS, tertiary lymphoid structure; GC, gastric cancer; CR, complete remission; PR, partial remission; PD, progressive disease; SD, stable disease.